Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) closed at $56.11 down -1.20% from its previous closing price of $56.79. In other words, the price has decreased by -$1.20 from its previous closing price. On the day, 2.04 million shares were traded.
Ratios:
For a deeper understanding of Biomarin Pharmaceutical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.24. For the most recent quarter (mrq), Quick Ratio is recorded 3.49 and its Current Ratio is at 5.52. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 20 ’25 when Burkhart Erin sold 1,786 shares for $59.31 per share. The transaction valued at 105,928 led to the insider holds 14,173 shares of the business.
Burkhart Erin bought 1,786 shares of BMRN for $105,928 on May 20 ’25. On May 02 ’25, another insider, Hubbard Cristin, who serves as the EVP, Chief Commercial Officer of the company, sold 273 shares for $64.92 each. As a result, the insider received 17,723 and left with 32,700 shares of the company.
Valuation Measures:
As of this moment, Biomarin’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.82, and their Forward P/E ratio for the next fiscal year is 13.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.68 while its Price-to-Book (P/B) ratio in mrq is 1.86.
Stock Price History:
Over the past 52 weeks, BMRN has reached a high of $94.85, while it has fallen to a 52-week low of $52.93. The 50-Day Moving Average of the stock is -8.42%, while the 200-Day Moving Average is calculated to be -17.35%.
Shares Statistics:
A total of 191.76M shares are outstanding, with a floating share count of 189.06M. Insiders hold about 1.42% of the company’s shares, while institutions hold 98.03% stake in the company.
